TITLE

The Serum Endothelın-1 Level in Steatosıs and NASH, and Its Relatıon wıth Severıty of Lıver Fıbrosıs

AUTHOR(S)
Seren Ozenirler; Sehri Elbeg; Gulen Akyol
PUB. DATE
October 2007
SOURCE
Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2622
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  Endothelin-1 (ET-1) is known to play an important role in hepatic fibrosis. ET-1 is also a mediator that is elevated in conditions such as insulin resistance, hyperglycemia, oxidative stress, and endothelial cell dysfunction. In this study, we investigated whether ET-1 has a role in determining the severity of liver fibrosis in NASH. Also, the relation between ALT levels, obesity, diabetes, and AST/ALT ratio and fibrosis and ET-1 level was sought. A total of 92 patients were enrolled in the study. The patients were categorized into three groups: group 1, patients with elevated transaminase levels who were diagnosed as NASH by liver biopsy (n=40); group II, patients with only hepatosteatosis determined by biopsy but having elevated transaminase levels (n=12); and group III, patients with hepatosteatosis observed by ultrasonography, having normal transaminase levels (n=40). The serum ET-1 level was measured by an appropriate ELISA kit for all patients. Mean serum ET-1 level was statistically significantly higher in the NASH group compared to the other two groups (15.56�4.63 vs 6.75�2.46 and 5.74�2.34 μmol/L; P P
ACCESSION #
26588675

 

Related Articles

  • High Plasma Concentrations of Endothelin-like Immunoreactivities in Patients with Hepatocellular Carcinoma. Nakamuta, Makoto; Ohashi, Masao; Tabata, Shinji; Tanabe, Yuichi; Goto, Kiminobu; Naruse, Mitsuhide; Naruse, Kiyoko; Hiroshige, Kaichiro; Nawata, Hajime // American Journal of Gastroenterology;Feb1993, Vol. 88 Issue 2, p248 

    The plasma levels of endothelin-like immunoreactivities (ET-IR) of patients with hepatocellular carcinoma (HCC) were compared with those of patients with liver cirrhosis (LC), using a specific radioimmunoassay for endothelin-1. The mean concentration of plasma ET-IR of 21 HCC patients (30.3 ±...

  • Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease. Colak, Yasar; Senates, Ebubekir; Ozturk, Oguzhan; Doganay, Hamdi Levent; Coskunpinar, Ender; Oltulu, Yasemin Musteri; Eren, Ayse; Sahin, Onder; Ozkanli, Seyma; Enc, Feruze Yilmaz; Ulasoglu, Celal; Tuncer, Ilyas // Metabolic Syndrome & Related Disorders;Apr2012, Vol. 10 Issue 2, p103 

    Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is...

  • Hepatitis: Epidemiology and Mainliners. Polk, Lewis D. // Clinical Pediatrics;Apr1971, Vol. 10 Issue 4, p191 

    The article presents information on the epidemiology of hepatitis. The epidemiology of hepatitis shows it to be a disease with multiyear cycles in the number of reported cases. Since 1952, when national hepatitis data were first collected by the Communicable Disease Center there have been peaks...

  • Evaluation of dual priming oligonucleotide-based multiplex PCR for detection of HBV YMDD mutants. Woo, H. Y.; Park, H.; Kim, B. I.; Jeon, W. K.; Kim, Y. J. // Archives of Virology;Nov2008, Vol. 153 Issue 11, p2019 

    We evaluated the usefulness of dual priming oligonucleotide (DPO)-based multiplex PCR, Seeplex HBV Lami-DR assay (Seegene Institute of Life Sciences, Seoul, Korea), to detect lamivudine-resistant HBV mutants in a comparison with the use of TRUGENEâ„¢ HBV genotyping and restriction fragment...

  • Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Rabe, Christian; Schmitz, Volker; Paashaus, Michael; Musch, Annemarie; Zickermann, Helga; Dumoulin, Franz-Ludwig; Sauerbruch, Tilman; Caselmann, Wolfgang H. // Intensive Care Medicine;Aug2004, Vol. 30 Issue 8, p1564 

    Objective: It is not known whether the poor outcome of ventilated cirrhotic patients is related to the severity of the underlying liver disease or to the severity of the acute illness for which ICU care is required. This study examines parameters both of chronic liver disease and of...

  • A disturbance of the gastric myoelectric activity in post-operative patients with biliary atresia. Ohtaki, Masahiro; Yagi, Minoru; Kubota, Masayuki; Homma, Shinji // Pediatric Surgery International;Feb2004, Vol. 20 Issue 2, p77 

    Background: Abnormalities in gastrointestinal motility have been reported in adult patients with advanced liver disease. However, there have so far been no reports on the gastric myoelectric activity in post-operative patients with biliary atresia (BA).Aim: The purpose...

  • Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration. Thürmann, Petra A.; Szymanski, Jacek; Haffner, Steffen; Tenter, Ute; Grieger, Frank; Sonnenburg, C. // European Journal of Clinical Pharmacology;Jul2006, Vol. 62 Issue 7, p511 

    This article focuses on the administration of antibody to hepatitis B surface antigen (anti-HBs)-enriched immunoglobulin in healthy volunteers. The authors administered the novel human hepatitis B immunoglobulin BT088 in thirty male and female healthy volunteers, with baseline anti-HBs...

  • Persistent Hypertransaminasemia as the Presenting Finding of Childhood Muscle Disease. Rutledge, Joe; Andersen, John; Fink, Chester W.; Cook, Jay; Strickland, Alan // Clinical Pediatrics;Sep1985, Vol. 24 Issue 9, p500 

    Four children with isolated, persistent elevations of serum transaminases were investigated for hepatic disease and followed for 4 to 24 months before serum creatine kinase determinations were obtained and found to be markedly elevated. Evidence of muscle disease was obtained by close...

  • Mycophenolate Mofetil for the Treatment of Primary Sclerosing Cholangitis. Talwalkar, Jayant A.; Angulo, Paul; Keach, Jill C.; Petz, Janice L.; Jorgensen, Roberta A.; Lindor, Keith D. // American Journal of Gastroenterology;Feb2005, Vol. 100 Issue 2, p308 

    Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology. Despite advances in understanding the pathophysiology underlying this disorder, no effective medical therapy has been identified for halting disease progression. The aim of this investigation was to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics